郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting.

期刊：Pharmaceutical development and technology发表年份：2019作者：Parisa Ghasemiyeh; Amir Azadi; Saeid Daneshamouz; Reza Heidari; Negar Azarpira; Soliman Mohammadi-Samani
阅读更多 →

药效评价Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes.

期刊：Biotechnology progress发表年份：2019作者：Matthew Manahan; Michael Nelson; Jonathan J Cacciatore; Jessica Weng; Sen Xu; Jennifer Pollard
阅读更多 →

药效评价A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.

期刊：Acta pharmacologica Sinica发表年份：2019作者：Mao-Xu Ge; Wei-Xiao Niu; Jin-Feng Ren; Shi-Ying Cai; Dong-Ke Yu; Hong-Tao Liu; Na Zhang; Yi-Xuan Zhang; Yu-Cheng Wang; Rong-Guang Shao; Ju-Xian Wang; Hong-Wei He
阅读更多 →

药效评价Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibody.

期刊：mAbs发表年份：2019作者：Douglas S Rehder; Chris J Wisniewski; Denfeng Liu; Diya Ren; Dell Farnan; Matthew R Schenauer
阅读更多 →